198 related articles for article (PubMed ID: 15990010)
1. Does altered fractionation influence the risk of radiation-induced optic neuropathy?
Bhandare N; Monroe AT; Morris CG; Bhatti MT; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1070-7. PubMed ID: 15990010
[TBL] [Abstract][Full Text] [Related]
2. Preventing radiation retinopathy with hyperfractionation.
Monroe AT; Bhandare N; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):856-64. PubMed ID: 15708266
[TBL] [Abstract][Full Text] [Related]
3. Analysis of Vision loss caused by radiation-induced optic neuropathy after particle therapy for head-and-neck and skull-base tumors adjacent to optic nerves.
Demizu Y; Murakami M; Miyawaki D; Niwa Y; Akagi T; Sasaki R; Terashima K; Suga D; Kamae I; Hishikawa Y
Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1487-92. PubMed ID: 19345516
[TBL] [Abstract][Full Text] [Related]
4. Radiation-induced optic neuropathy.
Danesh-Meyer HV
J Clin Neurosci; 2008 Feb; 15(2):95-100. PubMed ID: 18068989
[TBL] [Abstract][Full Text] [Related]
5. Ototoxicity after radiotherapy for head and neck tumors.
Bhandare N; Antonelli PJ; Morris CG; Malayapa RS; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2007 Feb; 67(2):469-79. PubMed ID: 17236969
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced optic neuropathy after stereotactic and image guided intensity-modulated radiation therapy (IMRT).
Brecht S; Boda-Heggemann J; Budjan J; Siebenlist K; Stieler F; Steil V; Wenz F; Lohr F; Buergy D
Radiother Oncol; 2019 May; 134():166-177. PubMed ID: 31005211
[TBL] [Abstract][Full Text] [Related]
7. Radiation-induced optic neuropathy after pencil beam scanning proton therapy for skull-base and head and neck tumours.
Kountouri M; Pica A; Walser M; Albertini F; Bolsi A; Kliebsch U; Bachtiary B; Combescure C; Lomax AJ; Schneider R; Weber DC
Br J Radiol; 2020 Mar; 93(1107):20190028. PubMed ID: 31322969
[TBL] [Abstract][Full Text] [Related]
8. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of anaplastic thyroid carcinoma treated with radiotherapy of once- and twice-daily fractionation regimens.
Wang Y; Tsang R; Asa S; Dickson B; Arenovich T; Brierley J
Cancer; 2006 Oct; 107(8):1786-92. PubMed ID: 16967442
[TBL] [Abstract][Full Text] [Related]
10. Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors.
Parsons JT; Bova FJ; Fitzgerald CR; Mendenhall WM; Million RR
Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):755-63. PubMed ID: 7960976
[TBL] [Abstract][Full Text] [Related]
11. Predictors of the therapeutic effect of corticosteroids on radiation-induced optic neuropathy following nasopharyngeal carcinoma.
Zheng B; Lin J; Li Y; Zhuo X; Huang X; Shen Q; Tang Y
Support Care Cancer; 2019 Nov; 27(11):4213-4219. PubMed ID: 30834973
[TBL] [Abstract][Full Text] [Related]
12. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
13. Radiation tolerance of the optic pathway in patients treated with proton and photon radiotherapy.
Li PC; Liebsch NJ; Niemierko A; Giantsoudi D; Lessell S; Fullerton BC; Adams J; Shih HA
Radiother Oncol; 2019 Feb; 131():112-119. PubMed ID: 30773177
[TBL] [Abstract][Full Text] [Related]
14. Hypopituitarism after radiotherapy for extracranial head and neck cancers in pediatric patients.
Bhandare N; Kennedy L; Malyapa RS; Morris CG; Mendenhall WM
Am J Clin Oncol; 2008 Dec; 31(6):567-72. PubMed ID: 19060589
[TBL] [Abstract][Full Text] [Related]
15. Optic neuropathy secondary to radiotherapy for nasal melanoma.
Garrott H; O'Day J
Clin Exp Ophthalmol; 2004 Jun; 32(3):330-3. PubMed ID: 15180849
[TBL] [Abstract][Full Text] [Related]
16. Radiation-induced optic neuropathy.
Sallet G; Kestelyn P
Bull Soc Belge Ophtalmol; 1992; 243():99-107. PubMed ID: 1302158
[TBL] [Abstract][Full Text] [Related]
17. [Radiation optic neuropathy after the brachytherapy of the uveal melanoma].
Szuścik I; Romanowska-Dixon B; Markiewicz A; Pogrzebielski A; Jakubowska B
Klin Oczna; 2006; 108(7-9):278-80. PubMed ID: 17290823
[TBL] [Abstract][Full Text] [Related]
18. Late-onset radiation-induced optic neuropathy after radiotherapy for nasopharyngeal carcinoma.
Zhao Z; Lan Y; Bai S; Shen J; Xiao S; Lv R; Zhang B; Tao E; Liu J
J Clin Neurosci; 2013 May; 20(5):702-6. PubMed ID: 23317755
[TBL] [Abstract][Full Text] [Related]
19. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and efficacy of subcutaneous amifostine therapy in patients with head and neck cancer treated with curative accelerated concomitant-boost radiation therapy.
Ozsahin M; Betz M; Matzinger O; Bron L; Luthi F; Pasche P; Azria D; Mirimanoff RO; Zouhair A
Arch Otolaryngol Head Neck Surg; 2006 Feb; 132(2):141-5. PubMed ID: 16490870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]